Sofosbuvir/Simeprevir/Daclatasvir/Ribavirin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sofosbuvir/Simeprevir/Daclatasvir/Ribavirin, covering 2020-05-14 to 2020-05-14. Get the full timeline:
Most recent: Clinical Trial Update: ٍٍSofosbuvir/Simeprevir/Daclatasvir/Ribavirin and HCV Genotype 4-infected Egyptian Experienced Participants [Phase 1, Phase 2]